Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -72.01%-66.23K | 136.47%32.48K | 78.86%-43.36K | -39.19%-357.39K | 66.22%-24.75K | -148.62%-38.51K | 55.02%-89.04K | -292.89%-205.09K | -18.84%-256.76K | -647.59%-73.26K |
| Net income from continuing operations | -458.13%-894.96K | 2.66%-243.87K | 44.25%-134.78K | -31.32%-970.02K | -30.95%-317.39K | 5.94%-160.35K | -70.57%-250.52K | -35.10%-241.76K | 56.13%-738.67K | 81.04%-242.37K |
| Operating gains losses | ---- | --10.58K | ---- | ---- | ---- | ---- | ---- | ---- | 304.98%92K | ---- |
| Depreciation and amortization | -76.05%8.23K | 1.55%35.13K | 6.44%36.28K | 9.99%138.54K | 3.34%35.52K | 1.24%34.34K | 1.79%34.59K | 43.98%34.09K | 56.75%125.96K | -20.31%34.37K |
| Remuneration paid in stock | --772.98K | --1.91K | --4.34K | -22.30%80.56K | --80.56K | --0 | --0 | --0 | -85.57%103.68K | --0 |
| Other non cashItems | -63.36%15.85K | -87.82%8.12K | 89.87%35.27K | 365.83%185.62K | 198.15%57.1K | 238.08%43.26K | 280.00%66.69K | 94.00%18.58K | 90.74%-69.83K | 81.11%-58.18K |
| Change In working capital | -28.42%31.67K | 266.45%220.6K | 197.05%15.53K | -9.65%207.91K | 18.38%119.46K | -74.99%44.24K | 173.84%60.2K | -117.11%-16K | -76.70%230.1K | -85.82%100.91K |
| -Change in receivables | -101.03%-35 | 275.72%31.69K | -512.95%-39.79K | -79.69%19.03K | 184.82%40.18K | -97.60%3.38K | 68.48%-18.04K | ---6.49K | 1,017.74%93.69K | 4.92%14.11K |
| -Change in inventory | 65.55%-11.27K | --52.45K | --3.73K | -2,852.16%-43.75K | -319.21%-11.05K | -578.53%-32.71K | --0 | --0 | -101.07%-1.48K | -96.50%5.04K |
| -Change in prepaid assets | 135.16%1.66K | -204.93%-3.28K | -89.46%6.53K | 180.28%52.63K | 86.59%-7.79K | 40.66%-4.71K | 609.55%3.12K | --62.01K | -2,684.75%-65.55K | -2,186.31%-58.06K |
| -Change in payables and accrued expense | -47.22%41.31K | 86.04%139.74K | 163.01%45.06K | -11.53%180K | -29.83%98.12K | 59.95%78.28K | 406.47%75.11K | ---71.51K | -75.86%203.44K | -74.63%139.83K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -72.01%-66.23K | 136.47%32.48K | 78.86%-43.36K | -39.19%-357.39K | 66.22%-24.75K | -148.62%-38.51K | 55.02%-89.04K | -292.89%-205.09K | -18.84%-256.76K | -647.66%-73.26K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -18.7K | -5.4K | 0 | 0 | 0 | |||||
| Net PPE purchase and sale | ---18.7K | ---5.4K | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---18.7K | ---5.4K | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 32.69%106.8K | 378.24%100.85K | -171.92%-42.22K | -66.58%179.71K | -71.87%76.77K | 335.35%80.49K | -148.67%-36.24K | -73.85%58.7K | 929.59%537.71K | 836.46%272.94K |
| Net issuance payments of debt | --0 | -7.09%-40.18K | 45.12%-42.22K | -222.24%-178.93K | -145.14%-25.55K | -13.83%-38.93K | -125.10%-37.52K | -201.66%-76.92K | 325.83%146.37K | 252.72%56.6K |
| Net common stock issuance | --101.5K | 16,135.16%207.81K | --0 | -68.06%125K | -100.92%-2.91K | --0 | -98.29%1.28K | -49.35%126.63K | --391.34K | --316.34K |
| Proceeds from stock option exercised by employees | -96.86%3.75K | --0 | --0 | --128.42K | --0 | --119.42K | --0 | --9K | --0 | --0 |
| Net other financing activities | --1.55K | ---66.78K | ---- | --105.22K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 32.69%106.8K | 378.24%100.85K | -171.92%-42.22K | -66.58%179.71K | -71.87%76.77K | 335.35%80.49K | -148.67%-36.24K | -73.85%58.7K | 929.59%537.71K | 836.46%272.94K |
| Net cash flow | ||||||||||
| Beginning cash position | 516.84%147.46K | -89.31%16.29K | -65.85%101.34K | 2,003.71%296.73K | -33.82%63.11K | -52.54%23.91K | -12.35%152.37K | 2,003.71%296.73K | -95.23%14.11K | 54.46%95.37K |
| Current changes in cash | -47.93%21.86K | 202.10%127.92K | 41.54%-85.58K | -163.24%-177.68K | -73.95%52.02K | -6.70%41.98K | -1.46%-125.28K | -184.96%-146.39K | 200.03%280.95K | 526.13%199.68K |
| Effect of exchange rate changes | -346.04%-12.38K | 202.20%3.25K | -73.97%530 | -1,157.16%-17.72K | -923.09%-13.8K | ---2.78K | ---3.18K | 116.22%2.04K | 315.15%1.68K | 315.15%1.68K |
| End cash Position | 148.67%156.94K | 516.84%147.46K | -89.31%16.29K | -65.85%101.34K | -65.85%101.34K | -33.82%63.11K | -52.54%23.91K | -12.35%152.37K | 2,003.71%296.73K | 2,003.71%296.73K |
| Free cash from | -120.58%-84.94K | 130.41%27.07K | 78.86%-43.36K | -39.19%-357.39K | 66.22%-24.75K | -148.62%-38.51K | 55.02%-89.04K | -292.89%-205.09K | -18.84%-256.76K | -647.66%-73.26K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.